Stocks
BioXcel (BTAI) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -42 012% | -41 969% | -11 987% | -2 467% | ||||
| Changes by years, y/y, % | +43pp | +29 982pp | -71.4% | ||||||
BioXcel. EBITDA margin, %
BioXcel. EBITDA margin, changes, pp
BioXcel (BTAI) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -13 828% | -4 985% | -3 970% | -409.6% | -4 571% | -2 467% | |
| Changes by years, y/y, % | +14 631pp | +16 816pp | +20 025pp | +10 554pp | +9 257pp | |||
| Changes by quarters, q/q, % | -2 865pp | +8 844pp | +1 015pp | +3 561pp | -4 162pp | |||
